| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.95B | 51.50B | 58.18B | 60.29B | 58.84B | 59.14B |
| Gross Profit | 32.60B | 30.93B | 33.10B | 34.26B | 33.41B | 32.78B |
| EBITDA | -198.50M | 1.23B | -977.00M | 2.63B | 1.83B | 3.42B |
| Net Income | -2.09B | 366.00M | -2.57B | 945.00M | 243.00M | 1.47B |
Balance Sheet | ||||||
| Total Assets | 29.29B | 32.59B | 34.05B | 37.26B | 37.24B | 38.63B |
| Cash, Cash Equivalents and Short-Term Investments | 8.21B | 11.32B | 11.30B | 12.18B | 14.74B | 15.01B |
| Total Debt | 8.00B | 8.00B | 8.00B | 8.00B | 8.00B | 8.00B |
| Total Liabilities | 14.72B | 17.88B | 15.25B | 15.05B | 15.16B | 16.19B |
| Stockholders Equity | 14.57B | 14.71B | 15.63B | 19.30B | 19.52B | 20.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 227.00M | 1.60B | -1.24B | 809.00M | 1.15B |
| Operating Cash Flow | 0.00 | 819.00M | 2.20B | 1.56B | 2.04B | 2.00B |
| Investing Cash Flow | 0.00 | 560.00M | -1.80B | -2.87B | -1.27B | -823.00M |
| Financing Cash Flow | 0.00 | -1.44B | -1.44B | -1.43B | -1.38B | -2.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥23.36T | 40.16 | 19.84% | 0.90% | 9.56% | 16.37% | |
73 Outperform | ¥736.10B | 17.77 | 8.48% | 2.02% | ― | ― | |
72 Outperform | ¥41.27B | -29.01 | ― | 3.62% | -0.98% | -29.86% | |
71 Outperform | ¥265.35B | 16.21 | ― | 1.46% | 12.02% | -15.70% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
50 Neutral | ¥27.33B | 75.72 | ― | 4.99% | -7.21% | -5127.88% |